Mechanisms regulating normal and ectopic endochondral ossification

正常和异位软骨内骨化的调节机制

基本信息

  • 批准号:
    9900719
  • 负责人:
  • 金额:
    $ 36.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

Endochondral ossification is the process by which long bones, ribs, vertebrae and other skeletal elements form and grow during embryogenesis and after birth. During this process, preskeletal mesenchymal cells condense and differentiate into cartilaginous anlaga that provide the template and framework of the future skeleton. Within these incipient structures, the chondrocytes become organized in growth plates, undergo maturation and hypertrophy, and pave the way for endochondral bone formation. This critical multi- step process is recapitulated in healing of most bone fractures, but can also be usurped in pathologies such as heterotopic ossification. HO consists of formation of endochondral bone that forms and accumulates at ectopic sites and causes many health problems. One form of HO is common and non-genetic and is triggered by trauma, invasive surgeries and ensuing inflammation. A congenital, severe and often fatal form of HO is initiated by local flare-ups and is driven by activating mutations in ACVR1 encoding the type I bone morphogenetic protein (BMP) receptor ALK2. Up until recently, the acquired and congenital forms of HO were thought to follow the same pathogenic cascade given that they both involve an initial inflammatory stage and a subsequent endochondral process. However, recent studies by others suggested that congenital HO is caused by activin A, normally an antagonist of BMP/canonical signaling that in this condition, however, would interact with mutant ALK2 and elicit pSMAD1/5/8 signaling. If correct, the data would imply that genetic and non- genetic forms of HO are distinct processes distinguishable by the manner in which they are triggered at cell level and may require distinct therapies. Because we have long been working on the pathogenesis of genetic and non-genetic forms of HO and have a vested interest, we carried out preliminary studies to further assess those recent studies. We found that activin A is actually abundantly expressed in both non-genetic and genetic HO in mouse models, greatly stimulates chondrogenesis in wild type preskeletal mesenchymal cells, and promotes HO in wild type mice. These and other data lead to the central premise of this project that both genetic and non-genetic forms of HO involve, and are promoted by, activin A. The greater severity of genetic HO would result from greater responsiveness of mutant chondrogenic progenitors to activin A and unruly mutant ALK2 signaling and action, but both non-genetic and genetic forms of HO would be amenable to an anti-activin A-based therapy. Our Aims are: (1) To clarify the mechanisms of activin A action in chondrogenesis; (2) To determine activin A receptor composition and cell surface dynamics; and (3) To genetically test the roles of activin A in HO and its usefulness as a therapy target. We anticipate this project will provide novel insights into the pathogenesis of genetic and non-genetic forms of HO and also fundamental basic insights into the regulation of endochondral ossification. It will also provide a springboard toward an effective universal therapy for HO in both children and adults.
软骨内骨化是指长骨、肋骨、椎骨和其他骨骼 元素在胚胎发育和出生后形成和生长。在这一过程中,骨前间充质 细胞凝聚和分化为软骨孔,提供了模板和框架 未来的骷髅。在这些初生的结构中,软骨细胞形成生长板, 经历成熟和肥大,为软骨内骨形成铺平道路。这一关键的多- 步骤过程在大多数骨折的愈合过程中被概括,但也可以在病理中被篡改,例如 异位骨化。HO包括在异位处形成并聚集的软骨内骨 并导致许多健康问题。一种形式的HO是常见的非遗传性的,由 创伤、侵入性手术和随之而来的炎症。一种先天性的、严重的、通常是致命的HO形式 由局部突发引发,由编码I型骨的ACVR1的激活突变驱动 形态发生蛋白受体ALK2。直到最近,后天的和先天的HO是 被认为遵循相同的致病级联,因为它们都涉及初始炎症阶段和 随之而来的软骨内过程。然而,最近其他人的研究表明,先天性HO是由 通过激活素A,通常是BMP/Canonical信号的拮抗剂,然而,在这种情况下,将相互作用 与突变型ALK2结合,诱导pSMAD1/5/8信号转导。如果正确,数据将暗示基因和非基因 HO的遗传形式是不同的过程,通过它们在细胞中被触发的方式来区分 水平,可能需要不同的治疗方法。因为我们长期以来一直致力于研究遗传病的发病机制 和非遗传形式的HO,并有既得利益,我们进行了初步研究,以进一步评估 那些最近的研究。我们发现激活素A实际上在非遗传性和遗传性中都大量表达 在小鼠模型中,HO极大地刺激野生型骨骼前间充质细胞的软骨形成,以及 在野生型小鼠中促进HO。这些数据和其他数据导致了该项目的中心前提是 遗传性和非遗传性HO涉及激活素A,并由激活素A促进。 HO可能是由于突变的软骨祖细胞对激活素A和不守规矩的更大的反应性所致 突变的ALK2信号和作用,但非遗传和遗传形式的HO将服从于 以抗激活素A为基础的治疗。我们的目标是:(1)阐明激活素A的作用机制 软骨形成;(2)测定激活素A受体组成和细胞表面动力学;以及(3) 从基因上测试激活素A在HO中的作用及其作为治疗靶点的有效性。我们预计这个项目将 为遗传性和非遗传性HO的发病机制提供新的见解,也为基础 对软骨内骨化调节的基本见解。它还将提供迈向 对儿童和成人的HO有效的普遍治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maurizio Pacifici其他文献

Maurizio Pacifici的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maurizio Pacifici', 18)}}的其他基金

Regulation of limb synovial joint organization and function
肢体滑膜关节组织和功能的调节
  • 批准号:
    10508521
  • 财政年份:
    2022
  • 资助金额:
    $ 36.68万
  • 项目类别:
Regulation of limb synovial joint organization and function
肢体滑膜关节组织和功能的调节
  • 批准号:
    10674028
  • 财政年份:
    2022
  • 资助金额:
    $ 36.68万
  • 项目类别:
2016 Bones & Teeth Gordon Research Conference and Gordon Research Seminar
2016 骨头
  • 批准号:
    9204947
  • 财政年份:
    2015
  • 资助金额:
    $ 36.68万
  • 项目类别:
2016 Bones & Teeth Gordon Research Conference and Gordon Research Seminar
2016 骨头
  • 批准号:
    9045147
  • 财政年份:
    2015
  • 资助金额:
    $ 36.68万
  • 项目类别:
Fourth International MHE Research Conference
第四届国际MHE研究会议
  • 批准号:
    8399406
  • 财政年份:
    2012
  • 资助金额:
    $ 36.68万
  • 项目类别:
Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome
遗传性多发性外生骨疣综合征的发病机制
  • 批准号:
    10442054
  • 财政年份:
    2011
  • 资助金额:
    $ 36.68万
  • 项目类别:
Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome
遗传性多发性外生骨疣综合征的发病机制
  • 批准号:
    10598638
  • 财政年份:
    2011
  • 资助金额:
    $ 36.68万
  • 项目类别:
Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome
遗传性多发性外生骨疣综合征的发病机制
  • 批准号:
    9309201
  • 财政年份:
    2011
  • 资助金额:
    $ 36.68万
  • 项目类别:
Mechanisms of Synovial Joint Formation
滑膜关节形成机制
  • 批准号:
    7413662
  • 财政年份:
    2005
  • 资助金额:
    $ 36.68万
  • 项目类别:
Mechanisms of Synovial Joint Formation
滑膜关节形成机制
  • 批准号:
    7235656
  • 财政年份:
    2005
  • 资助金额:
    $ 36.68万
  • 项目类别:

相似海外基金

心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
  • 批准号:
    24K11201
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
  • 批准号:
    24K11281
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
  • 批准号:
    EP/Z001145/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
  • 批准号:
    2338890
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334777
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334775
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334776
  • 财政年份:
    2024
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
  • 批准号:
    2320040
  • 财政年份:
    2023
  • 资助金额:
    $ 36.68万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了